HUMA (Humacyte) Beginning Cash Position: $50.85 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HUMA Humacyte Inc HUMA
21 GF Score
Price $0.62
! 6 Warning Signs
View Full Analysis

What is Humacyte Beginning Cash Position?

Humacyte HUMA -0.94% 21 Beginning Cash Position is $50.85 Mil as of Mar. 2026. GuruFocus rates HUMA with a GF Score™ of 21/100. The stock has 6 warning signs investors should review.

Humacyte's Beginning Cash Position for the quarter that ended in Mar. 2026 was $50.85 Mil.

Humacyte's quarterly Beginning Cash Position declined from Sep. 2025 ($88.39 Mil) to Dec. 2025 ($19.84 Mil) but then increased from Dec. 2025 ($19.84 Mil) to Mar. 2026 ($50.85 Mil).

Humacyte's annual Beginning Cash Position declined from Dec. 2023 ($149.77 Mil) to Dec. 2024 ($80.80 Mil) but then increased from Dec. 2024 ($80.80 Mil) to Dec. 2025 ($95.29 Mil).

Humacyte Beginning Cash Position Related Terms

Humacyte Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Humacyte's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Humacyte Beginning Cash Position Chart

Humacyte Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 39.93 217.50 149.77 80.80 95.29

Humacyte Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.29 113.20 88.39 19.84 50.85
HUMA
21GF Score
Humacyte Inc HUMA
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Humacyte Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $50.85 Mil mean?
Humacyte (HUMA) has a Beginning Cash Position of $50.85 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Humacyte and its competitors.
Is Humacyte's Beginning Cash Position too high?
Humacyte's current Beginning Cash Position is $50.85 Mil. Overall, Humacyte has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Humacyte's Beginning Cash Position compare to CRBP and OKUR?
Humacyte's Beginning Cash Position of $50.85 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Humacyte and its competitors. Humacyte's current Beginning Cash Position is $50.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humacyte stock overvalued right now?
Humacyte (HUMA) has a current Beginning Cash Position of $50.85 Mil. The current Beginning Cash Position is $50.85 Mil. Humacyte's overall GF Score™ is 21/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Humacyte (HUMA), the current Beginning Cash Position is $50.85 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Humacyte Business Description

Address 2525 East North Carolina Highway 54, Durham, NC, USA, 27713
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
21GF Score

Get the complete analysis for HUMA

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.62
Price